Allogene Therapeutics
A biotechnology company catalyzing cancer treatment through the development of CAR T therapy. Learn more
Launch date
Employees
Market cap
€508m
Enterprise valuation
€182m (Public information from Sep 2024)
Share price
$2.67 ALLO
San Francisco California (HQ)
Authorizing premium user...